Showing results (71-80 of 123) with videos related to
Sort By:
Pageof 13
JAMA Surgery|November 23, 2022
Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant TherapyAbdulrahman Y Hammad, Jacob C Hodges, Samer AlMasri, et al.Journal of Gastrointestinal Oncology|September 12, 2017
A margin distance analysis of the impact of adjuvant chemoradiation on survival after pancreatoduodenectomy for pancreatic adenocarcinomaLee M Ocuin, Jennifer L Miller-Ocuin, Mazen S Zenati, et al.Developmental Biology|March 6, 2003
Characterization of embryonic globin genes of the zebrafishAlison Brownlie, Candace Hersey, Andrew C Oates, et al.AJR. American Journal of Roentgenology|December 5, 2019
Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal AdenocarcinomaAmir A Borhani, Rohit Dewan, Alessandro Furlan, et al.The American Journal of Surgical Pathology|January 31, 2015
Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survivalAatur D Singhi, Tyler J Foxwell, Katie Nason, et al.Frontiers in Oncology|August 2, 2021
Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal IrinotecanKenneth H Yu, Andrew E Hendifar, Olatunji B Alese, et al.Cancer Medicine|December 29, 2016
Impact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignanciesMashaal Dhir, Haroon A Choudry, Matthew P Holtzman, et al.Journal of Cell Science|September 14, 2006
A novel endothelial-specific heat shock protein HspA12B is required in both zebrafish development and endothelial functions in vitroGuang Hu, Jian Tang, Bo Zhang, et al.JAMA Network Open|June 23, 2022
Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic CancerSamer AlMasri, Mazen Zenati, Abdulrahman Hammad, et al.American Journal of Clinical Oncology|April 24, 2014
Lapatinib and gemcitabine for metastatic pancreatic cancer. A phase II studyHoward Safran, Thomas Miner, Nathan Bahary, et al.Pageof 13